Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...
As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...
The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...
The second executive at a drugmaker said his company was "stockpiling" in the United States, the pharma industry's ...
Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.
Tariffs are one way for Donald Trump to achieve tax cuts, and Irish-based pharma industry may be a golden goose ready for ...
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.
Europe's pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by President Donald Trump fade.
As U.S. President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback